Variant report
Variant | nsv511985 |
---|---|
Chromosome Location | chr7:108351650-108354930 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:108354711..108356531-chr7:108358919..108360858,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181390422 | chr7:108351815-108351816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543489086 | chr7:108351838-108351839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184281162 | chr7:108351870-108351871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2028039 | chr7:108351888-108351889 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs73714705 | chr7:108351891-108351892 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs57973513 | chr7:108351904-108351905 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs543340102 | chr7:108351963-108351964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189000695 | chr7:108351965-108351966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539757032 | chr7:108351970-108351971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558011605 | chr7:108351995-108351996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532408386 | chr7:108352053-108352054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551488648 | chr7:108352069-108352070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571578005 | chr7:108352077-108352078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527829655 | chr7:108352096-108352097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547911365 | chr7:108352104-108352105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567889960 | chr7:108352166-108352167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536828932 | chr7:108352203-108352204 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs60645835 | chr7:108352276-108352277 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556680779 | chr7:108352319-108352320 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570273185 | chr7:108352355-108352356 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539270770 | chr7:108352365-108352366 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558275637 | chr7:108352400-108352401 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571696255 | chr7:108352481-108352482 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540772861 | chr7:108352509-108352510 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12705490 | chr7:108352520-108352521 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs559123748 | chr7:108352543-108352544 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574326150 | chr7:108352552-108352553 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543274349 | chr7:108352566-108352567 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs71568543 | chr7:108352589-108352590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563451528 | chr7:108352619-108352620 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs6951726 | chr7:108352624-108352625 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs111922787 | chr7:108352626-108352627 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113903397 | chr7:108352675-108352676 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546071310 | chr7:108352691-108352692 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140082827 | chr7:108352716-108352717 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527666405 | chr7:108352744-108352745 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10216082 | chr7:108352758-108352759 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs561386956 | chr7:108352780-108352781 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs146844516 | chr7:108352796-108352797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530187372 | chr7:108352804-108352805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550108315 | chr7:108352808-108352809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570189152 | chr7:108352813-108352814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562248745 | chr7:108352829-108352830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs141491242 | chr7:108352830-108352831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs149231188 | chr7:108352858-108352859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145895022 | chr7:108352859-108352860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138061090 | chr7:108352860-108352861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574198755 | chr7:108352862-108352863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537110794 | chr7:108352866-108352867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556918816 | chr7:108352867-108352868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16397240 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Autism | 19401682 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Autism | 20841430 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:108351800-108352200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr7:108351800-108352200 | Enhancers | Fetal Stomach | stomach |
3 | chr7:108351800-108352200 | Enhancers | Dnd41 | blood |
4 | chr7:108351800-108352400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr7:108352000-108352800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr7:108352200-108352800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
7 | chr7:108352200-108356800 | Weak transcription | Fetal Stomach | stomach |
8 | chr7:108352200-108357000 | Weak transcription | Dnd41 | blood |
9 | chr7:108352400-108354600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr7:108354600-108355000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |